Phoenix Rising tells QMUL: release the PACE trial data
Mark Berry, Acting CEO of Phoenix Rising, presents the Board of Directors’ open letter to Queen Mary University of London (QMUL) urging them to release the PACE trial data, and hopes that other non-UK organisations will join British charities in the same request...
Discuss the article on the Forums.

Pfizer Moves May Dim Prospect for New Antibiotics

Discussion in 'Other Health News and Research' started by leelaplay, Feb 6, 2011.

  1. leelaplay

    leelaplay member

    Messages:
    1,542
    Likes:
    119
    http://www.medpagetoday.com/Infecti...ailyHeadlines&utm_source=mSpoke&userid=242714

    "The plan will not sit well with the infectious disease community, said Brad Spellberg, MD, of the University of California Los Angeles, and a member of IDSA's Antimicrobial Availability Task Force.

    "It's just a crushing blow," he told MedPage Today in a phone interview. He said Pfizer had been one of a handful of big companies in the antibiotic field and that the decision would have a crippling effect on antibiotic development."
     

See more popular forum discussions.

Share This Page